News

Veterans Gain Access to Groundbreaking Hypertension Therapy

Veterans Gain Access to Groundbreaking Hypertension Therapy

A New Hope for Veterans Battling Hypertension

Ultrasound Renal Denervation (uRDN) is transforming the treatment landscape for veterans struggling with high blood pressure. This effective therapy has been made possible through a collaboration between Recor Medical and Recon Supply, offering a solution that provides hope to many.

Understanding Hypertension and Its Risks

Hypertension, often referred to as the "silent killer," can lurk unnoticed, leading to severe health complications such as heart disease and stroke. Statistics reveal that a significant percentage of veterans are affected, with many categorized as having uncontrolled hypertension, according to established healthcare guidelines.

The Quest for Effective Treatment

For many individuals diagnosed with uncontrolled hypertension, traditional treatments such as dietary changes and medication often fall short. While lifestyle modifications are essential, they may not be sufficient for everyone. This is where advanced treatments like the Paradise uRDN system come into play, offering new possibilities for those who have exhausted conventional options.

A Personal Journey: Richard's Experience

Army veteran Richard Van Name found himself in this exact situation. After years of service and adjusting his lifestyle, he faced persistent high blood pressure. Despite the medication and positive changes, he remained at risk. After discussions with his healthcare provider, Richard decided to try the Paradise uRDN treatment, which was presented as a minimally invasive yet impactful alternative.

What is the Paradise uRDN System?

The Paradise uRDN technology sets itself apart as a pioneering treatment for hypertension, utilizing ultrasound energy to denervate sympathetic nerves near the renal arteries. This specific action can significantly reduce the overactivity contributing to high blood pressure. The procedure is designed to be safe, effective, and supportive of overall heart health.

Support and Partnership in Veterans' Health

Recor Medical, renowned for its innovation in hypertension treatment, has partnered with Service-Disabled Veteran Owned Small Business, Recon Supply, to ensure the effective distribution of the Paradise system within the Veterans Health Administration. This partnership reflects a deep commitment to enhancing health outcomes for veterans.

Clinical Backing and Future Aspirations

Since its inception in 2009, Recor has rigorously tested the uRDN systems, culminating in multiple clinical trials that have underscored their efficacy. The recent FDA approval reinforces the confidence in this treatment modality. To further understand the long-term impacts and effectiveness of the Paradise uRDN system, Recor has initiated the US Global Paradise System (GPS) Post-Approval Study.

Benefits and Risks of Paradise uRDN

While the Paradise uRDN presents many potential benefits for treating hypertension, patients should engage in detailed discussions with their healthcare providers about the potential risks. Although the procedure is generally safe, as with any medical intervention, it can have complications that need consideration.

A Commitment to Our Veterans

For veterans and their families, the introduction of the Paradise uRDN treatment represents more than just a medical option; it symbolizes hope and a future where managing hypertension becomes more accessible and effective. The collaboration between Recor Medical and Recon Supply is poised to make a significant impact in the lives of those who served.

Frequently Asked Questions

What is Ultrasound Renal Denervation?

Ultrasound Renal Denervation is a minimally invasive procedure designed to lower blood pressure by disrupting nerves around the renal arteries.

Who can benefit from the Paradise uRDN treatment?

Veterans with uncontrolled hypertension who have not found adequate control through lifestyle changes and medications may be candidates.

How does the uRDN procedure work?

The procedure utilizes ultrasound energy to target and reduce nerve activity, aimed at achieving better blood pressure control.

Is the treatment supported by clinical research?

Yes, the uRDN system has undergone extensive clinical trials demonstrating its safety and efficacy, leading to FDA approval.

How can veterans access the Paradise uRDN system?

Access to the Paradise uRDN treatment is facilitated through partnerships between Recor Medical and veteran health organizations, ensuring its availability to those who need it.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 158

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 132

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 152

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 129

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 201

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 94

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
vVARDIS Debuts on NYSE: Transforming Dental Care

Updated Category News Views 92

A New Chapter for Dental Tech Mark your calendars, folks. vVARDIS is stepping onto the New York Stock Exchange (NYSE) stage, waving the banner of NYSE:VVVV. Now, if you've ever sat in that squeaky dental chair feeling the dread of a drill, vVARDIS might just be the new hero in town. Founded by the dynamic duo, Dr. Haley and Dr. Goly Abivardi, they're on a mission to...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 147

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading

Top 5 Most Recently Viewed Articles

Chris Larsen's Strategic XRP Moves: Implications for Investors

Updated Category News Views 333

Overview of Chris Larsen's Recent XRP Transactions Chris Larsen, the influential co-founder and executive chairman of Ripple, has been actively transferring substantial amounts of XRP. Recently, he moved approximately $26 million worth of XRP to Coinbase, one of the most prominent cryptocurrency exchanges. This transfer is part of a larger pattern, contributing to an...

Continue Reading
Mastercard's Options Activity Insights: Market Trends Explored

Updated Category News Views 143

Understanding Mastercard's Recent Options Activity Mastercard is currently in the spotlight as investors engage in noteworthy bearish actions. This indicates a prevailing sentiment among wealthy clients regarding their perspective on the financial giant. Investor Insights on Mastercard Our analysis indicates that certain trades of interest have emerged in the options...

Continue Reading
Discover How CryptoGO Revolutionizes Memecoin Trading

Updated Category News Views 222

Transforming Memecoin Trading for Beginners CryptoGO is a innovative Telegram mini-app crafted specifically to ease the entry of newcomers into the world of memecoin trading. By harnessing the power of the Solana blockchain, CryptoGO revolutionizes how users engage with meme tokens, making the process both accessible and enjoyable. With support for fiat currency, users...

Continue Reading
Pyxis Oncology Updates on Financial Status and Future Plans

Updated Category News Views 325

Latest Developments at Pyxis Oncology Pyxis Oncology, Inc. has recently made headlines with its remarkable progress in the field of oncology. The development and ongoing trials of their innovative therapy, micvotabart pelidotin (MICVO), have shown encouraging preclinical results, highlighting its unique three-pronged mechanism of action. This mechanism enhances anti-tumor...

Continue Reading
Florida’s Cannabis Legalization Gains Momentum with Herald Support

Updated Category News Views 93

Support for Cannabis Legalization Gains Traction The Miami Herald, a notable publication in Florida with a rich history dating back to 1903, has come out strongly in favor of the state's cannabis legalization initiative known as Amendment 3. The proposal will be presented to voters in the upcoming election, marking a significant shift in public policy towards cannabis....

Continue Reading